 |
|
|
| |
Response-guided long-term treatment of chronic hepatitis D
patients with bulevirtide -Results of a "real world study"
|
| |
| |
EASL 2022 June 22-26 London
M. JACHS1, C. SCHWARZ2, M. PANZER3, T. BINTER1, S. ABERLE4, A.F. STÄTTERMAYER1, H. ZOLLER3, M. GSCHWANLTER2, M. TRAUNER1, T. REIBERGER1,2,#, P. FERENCI1,#
1 Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria 2 Department of Internal Medicine IV; Klinik Ottakring, Vienna, Austria
3 Department of Internal Medicine I, Medical University of Innsbruck, Innsbruck, Austria
4 Center for Virology, Medical University of Vienna, Vienna, Austria
# T.R. and P.F. contributed equally and share the senior authorship
|
| |
|
|
|
|
|
